The Latest Advancement in Regenerative Medicine Is Lab-Grown Vaginas

Medical research continues to succeed in engineering organs. But that’s not enough.

Yes, that is what the headline implies.
National Journal
Brian Resnick
Add to Briefcase
Brian Resnick
April 10, 2014, 2:30 p.m.

Add nos­trils and va­gi­nas to the read­ily ex­pand­ing list of hu­man tis­sues doc­tors can now grow in labor­at­or­ies and suc­cess­fully im­plant in pa­tients.

Two long-term stud­ies just pub­lished in the in­flu­en­tial med­ic­al journ­al The Lan­cet out­line the suc­cess doc­tors have achieved in trans­plant­ing both body parts. In the first study, doc­tors at Wake Forest Uni­versity har­ves­ted cells from the gen­it­als of four teen­age girls born with a syn­drome that res­ults in un­der­developed sexu­al or­gans, coaxed those cells in­to a re­gen­er­at­ive state, grew them on a scaf­fold, and then trans­planted the res­ult­ing tis­sue.

After eight years of fol­low up, “the or­gans con­tin­ue to func­tion as if they were nat­ive tis­sue and all re­cip­i­ents are sexu­ally act­ive, re­port no pain, and are sat­is­fied with their de­sire/arous­al, lub­ric­a­tion, and or­gasm.”

In the second study, five people had their nos­trils re­con­struc­ted with their own car­til­age. That tis­sue was har­ves­ted from their own noses, and coaxed in­to ex­pand­ing in volume by a factor of 40. It was then im­planted. The re­search con­cludes that “the clin­ic­al re­con­struc­tion of the nas­al [lobe] after re­sec­tion of a non-melan­oma skin can­cer is safe and feas­ible.”

While these find­ings are cer­tainly eye­brow-rais­ing — and lend hope to those suf­fer­ing with dis­fig­ur­a­tion — the more im­port­ant as­pect of their pub­lic­a­tion can be found in an op-ed pub­lished along­side the re­search.

Drs. Mar­tin A. Birch­all, and Al­ex­an­der M. Sei­fali­an write that these find­ings can be just as frus­trat­ing as they are prom­ising. This re­search is con­sidered dis­rupt­ive medi­cine, and dis­rup­tions can take a very, very long time to make their way in­to main­stream medi­cine. And the high cost of de­vel­op­ing such tech­no­logy of­ten poses road­b­locks. Birch­all and Sei­fali­an write:

MRI scan­ners con­tin­ue to im­prove gen­er­a­tion­ally. These changes, which im­prove the pa­tient’s ex­per­i­ence and ac­cur­acy of dia­gnos­is, are sus­tain­ing in­nov­a­tions: they im­prove an ex­ist­ing sys­tem that is un­der­stood by pa­tients and that sup­ports spe­cial­ised in­dustry, doc­tors, and health-care sys­tems. By con­trast, tis­sue en­gin­eer­ing, and the vari­ous shades of re­gen­er­at­ive and cel­lu­lar ther­apies it part­ners, is a dis­rupt­ive tech­no­logy. …

Early auto­mobile tech­no­logy, al­though highly in­nov­at­ive, was the pre­serve of those who could af­ford it for many years. It was only when Henry Ford’s mass pro­duc­tion brought auto­mo­biles to every­one’s street, in num­bers yet at af­ford­able cost, that the in­dustry of the horse-drawn car­riage passed away. These two Lan­cet stud­ies show that those who prac­tise con­ven­tion­al tis­sue re­con­struc­tion and or­gan trans­plant­a­tion, and the health-care and com­mer­cial in­dus­tries which sup­port them, should fi­nally be tak­ing the quirky min­nows of tis­sue en­gin­eer­ing quite ser­i­ously. Dis­rupt­ive in­nov­a­tion might be nigh.

As I wrote in Novem­ber, it will be some time be­fore lab-grown or­gans are com­monly avail­able. Clin­ic­al tri­als for new pro­ced­ures take dec­ades. And “private in­dustry is go­ing to have to raise mil­lions and mil­lions of dol­lars not around the sci­ence, but around the prac­tic­al­ity,” Wil­li­am Wag­n­er, dir­ect­or of re­gen­er­at­ive medi­cine at the Uni­versity of Pitt­s­burgh, told me then.

Road­b­locks in­volving time and money are not ex­clus­ive to re­gen­er­at­ive medi­cine. Take an­ti­bi­ot­ic re­search. Ap­provals of new an­ti­bi­ot­ics are cur­rently at their low­est rate, at a time when threat of drug-res­ist­ant strains haven’t been high­er. Or even sun­screen. In­gredi­ents that European com­pan­ies have been us­ing for years, which work bet­ter than the ones cur­rently avail­able in the United States, are stuck in reg­u­lat­ory limbo.

That’s why Birch­all and Sei­fali­an provide a good re­mind­er: Let’s turn some of these gee-whiz stud­ies in­to real­ity.

What We're Following See More »
DOCUMENTS OBTAINED BY U.S. INTEL
Putin-Linked Think Tank Developed Plan to Influence U.S. Election
3 days ago
THE LATEST

A Russian government think tank run by Putin loyalists "developed a plan to swing the 2016 U.S. presidential election to Donald Trump and undermine voters’ faith in the American electoral system." Two confidential documents from the Putin-backed Institute for Strategic Studies, obtained by U.S. intelligence, provide "the framework and rationale for what U.S. intelligence agencies have concluded was an intensive effort by Russia to interfere with the Nov. 8 election."

Source:
HELPED WIN FISA APPROVAL
FBI Relied on Dossier Allegations to Monitor Page
4 days ago
THE LATEST

"The FBI last year used a dossier of allegations of Russian ties to Donald Trump's campaign as part of the justification" to monitor Carter Page, who was then a defense adviser to the Trump campaign. "The dossier has also been cited by FBI Director James Comey in some of his briefings to members of Congress in recent weeks."

Source:
AIR FORCE SCRAMBLES JETS IN RESPONSE
Russian Bombers Fly Near Alaska
5 days ago
WHY WE CARE
A MESSAGE TO RUSSIA?
Pentagon Deploying F-35s to Europe
1 weeks ago
THE LATEST

"The Air Force is set to deploy its high-tech, fifth-generation F-35A fighter jets to Europe this weekend as part of an effort to assure U.S. allies there who are worried about Russian aggression." The new, state-of-the-art fighters will train with European air units. "The Pentagon noted that the deployment had been long planned, meaning it was not a reaction to recent increasing tensions between the United States and Russia," although a statement noted the move is part of the "European Reassurance Initiative," which began three years ago when Russia annexed Crimea.

Source:
NOT ON SCHEDULE
Tillerson Meets Putin
1 weeks ago
BREAKING
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login